Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD

Patients with CKD often progress to ESRD and develop cardiovascular disease (CVD), yet available therapies only modestly improve clinical outcomes. Observational studies report independent associations between elevated serum phosphate and fibroblast growth factor 23 (FGF23) levels and risks of ESRD,...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Am Soc Nephrol
Egile Nagusiak: Isakova, Tamara, Ix, Joachim H., Sprague, Stuart M., Raphael, Kalani L., Fried, Linda, Gassman, Jennifer J., Raj, Dominic, Cheung, Alfred K., Kusek, John W., Flessner, Michael F., Wolf, Myles, Block, Geoffrey A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Nephrology 2015
Gaiak:
Up Front Matters
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4587706/
https://ncbi.nlm.nih.gov/pubmed/25967123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2015020117
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak